Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart A Westerman

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Plos One|May 11, 2012
GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumorsBart A Westerman, Marleen Blom, Ellen Tanger, et al.
Nature Cell Biology|January 8, 2020
p120-catenin-dependent collective brain infiltration by glioma cell networksPavlo G Gritsenko, Nader Atlasy, Cindy E J Dieteren, et al.
Cell Reports|October 19, 2017
Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of InflammationYotam E Bar-Ephraim, Ferry Cornelissen, Natalie Papazian, et al.
The Journal of Experimental Medicine|December 7, 2011
A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiationBart A Westerman, A Koen Braat, Nicole Taub, et al.
The Oncologist|December 15, 2025
Recurrent Hematological Toxicity After Second-Line Treatment in Patients with Glioblastoma: Indication of a Potential PredispositionLeon van Hout, Femke E L van den Elzen, Zoë de Jong, et al.
Molecular Human Reproduction|June 23, 2004
The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentasCees B M Oudejans, Joyce Mulders, Augusta M A Lachmeijer, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided VerificationSuzanne van der Gaag, Tamara Jordens, Maqsood Yaqub, et al.
Molecular Cancer Therapeutics|September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of GlioblastomaRavi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Cancer Cell|November 4, 2015
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer DiagnosticsMyron G Best, Nik Sol, Irsan Kooi, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Plos One|May 11, 2012
GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumorsBart A Westerman, Marleen Blom, Ellen Tanger, et al.
Nature Cell Biology|January 8, 2020
p120-catenin-dependent collective brain infiltration by glioma cell networksPavlo G Gritsenko, Nader Atlasy, Cindy E J Dieteren, et al.
Cell Reports|October 19, 2017
Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of InflammationYotam E Bar-Ephraim, Ferry Cornelissen, Natalie Papazian, et al.
The Journal of Experimental Medicine|December 7, 2011
A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiationBart A Westerman, A Koen Braat, Nicole Taub, et al.
The Oncologist|December 15, 2025
Recurrent Hematological Toxicity After Second-Line Treatment in Patients with Glioblastoma: Indication of a Potential PredispositionLeon van Hout, Femke E L van den Elzen, Zoë de Jong, et al.
Molecular Human Reproduction|June 23, 2004
The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentasCees B M Oudejans, Joyce Mulders, Augusta M A Lachmeijer, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided VerificationSuzanne van der Gaag, Tamara Jordens, Maqsood Yaqub, et al.
Molecular Cancer Therapeutics|September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of GlioblastomaRavi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Cancer Cell|November 4, 2015
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer DiagnosticsMyron G Best, Nik Sol, Irsan Kooi, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pageof 5